Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation
Open Access
- 31 January 2004
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (1) , 65-72
- https://doi.org/10.1016/j.bbmt.2003.09.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control studyTransplantation and Cellular Therapy, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsBlood, 2001
- High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationBone Marrow Transplantation, 2000
- Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancyAnnals of Oncology, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's LymphomaBlood, 1997
- Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effectBone Marrow Transplantation, 1997